Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > BROWSE ARTICLES > Author index
Search
Yoon Hee Choi  (Choi YH) 3 Articles
The Short-term Effects of Bone Marrow Transplantation on Bone Metabolism.
Soon Jib Yoo, Yoo Bae Ahn, Kun Ho Yoon, Moo Il Kang, Kwang Woo Lee, Ho Young Son, Sung Koo Kang, Ki Ho Song, Yoon Hee Choi, Bong Yeon Cha, Hye Soo Kim, Ki Won Oh, Sung Dae Moon, Sang Ah Jang, Chun Choo Kim
J Korean Endocr Soc. 1999;14(2):355-364.   Published online January 1, 2001
  • 1,101 View
  • 18 Download
AbstractAbstract PDF
BACKGROUND
The organ transplantation becomes the management of choice for many patients with chronic and life threatening heart, liver, kidney, bone marrow, and pancreatic diseases. A new set of side effects unique to this groups of patients has become recognized. Bone disease is one of these complications. It is well known that there is an interplay between the cells in the bone marrow and the surrounding bone tissue. Marrow stromal cells include the progenitors of the osteoblastic lineage are the sources of effector molecules that support and regulate both hematopoiesis and bone remodeling. But little is known about the effects of myeloablative treatment followed by bone marrow transplantation(BMT) on bone metabolism. METHODS: We have investigated prospectively in 29 patients undergoing BMT(4 autologous, 25 allogenic) for hematologic diseases(19 leukemia, 9 severe aplastic anemia, 1 myelodyspoietic syndrome). Serum concentrations of calcium, phosphorus, creatinine, gonadotropins, sex hormones and biochemical markers of bone turnover(osteocalcin and carboxyterminal cross-linked telopeptide of type I collagen(ICTP)] were measured. The samples were collected before BMT and 1, 2, 3, 4, 12 weeks, 6 months and 1 year thereafter. Bone mineral density was measured with DEXA(Dual Energy X-ray Absorptiometry) before and after 1 year of BMT. RESULTS: 1. ICIP was progressively increased until 4 weeks after BMT when peak values were reached. And then decreased thereafter and basal values were regained after 1 year. Osteocalcin was progressively decreased until 3 weeks after BMT when nadir values were reached. And then increased thereafter and basal values were regained after 3 months. No distinct differences were observed in serum biochemical turnover marker between both sexes and between patients who received total body irradiation and those who did not. 2. Lumbar BMD was 2.1% decreased from 1.113 +/- 0.132 g/cm to 1.089 +/- 0.137 g/cm, and femoral BMD was 6.2% decreased fiom 1.078 +/- 0.156 g/cm to 1.011 +/- 0.157 g/cm. 3. 92% of the women (11/12) became menopausal manifested by high gonadotropin and low estradiol levels immediately after BMT. In contrast to women, gonadotropins and testosterone levels were not changed significantly in men after BMT. CONCLUSION: The rapid impairment of bone formation and also increase in bone resorption, as mirrored by the biochemical markers in this study, might play a role for the post-BMT bone loss. Further studies over many patients with a longer follow up will be needed.
Close layer
A Case of Alstrom Syndrome.
Kun Ho Yoon, Ho Young Son, Sung Koo Kang, Yoon Hee Choi, Bong Yeon Cha, Hwan Suk Cho, Ki Bum Kim, Ji Ho Kang, Young Mi Choo, Sang Soo Bae
J Korean Endocr Soc. 1998;13(3):501-508.   Published online January 1, 2001
  • 1,099 View
  • 16 Download
AbstractAbstract PDF
The Alstrom syndrome is inherited autosomal recessive disorder, characterized by obesity, diabetes mellitus, pigmentary retinal degeneration, normal intelligence, sensorineural hearing loss, baldness, acanthosis nigricans, male hypogonadism, hyperuricemia and hypertriglyceridemia. There is no reported case of Alstrom syndrome in Korea yet. We experienced a 29-year-old female patient with clinical characteristics similar to Alstrom syndrome who was admitted due to poorly controlled diabetes mellitus and diabetic retinopathy with hemorrhage. We report this case with the review of literatures.
Close layer
A Case of Functioning Parathyroid Cancer with Hypokalemia.
Yoon Hee Choi
J Korean Endocr Soc. 1997;12(1):81-89.   Published online January 1, 2001
  • 1,038 View
  • 17 Download
AbstractAbstract PDF
The parathyroid carcinoma is rare disorder and its reported incidence is 1-2% of primary hyperparathyroidism. Parathyroid cancer shows more profound clinical symptoms and signs than adenoma or hyperplasia: more severe renal and bony complications, higher calcium levels (>15 mg/dL) and palpable neck mass. It usually diagnosed after operation when it shows malignant pathologic findings, local invasion, distant metastasis, or even recurrence. The treatment is surgical resection. Hypokalemia is relatively common feature of primary hyperparathyroidism but it should be marked because of its arrhythmogenic effect when accompanies with hypercalcemia. We experienced a hyperfunctioning parathyroid carcinoma in 53 year old rnan confirmed postoperatively which showed hypokalemia normalized after operation.
Close layer

Endocrinol Metab : Endocrinology and Metabolism